$AURX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Nuo Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Nuo Therapeutics, Inc.. Get notifications about new insider transactions in Nuo Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 14 2009 | NUOT | Nuo Therapeutics, ... | ROSENDALE MARTIN P | CHIEF EXECUTIVE OFF ... | Option Exercise | P | 0.65 | 8,750 | 5,688 | 725,417 | |
Aug 14 2009 | NUOT | Nuo Therapeutics, ... | ROSENDALE MARTIN P | CHIEF EXECUTIVE OFF ... | Buy | P | 0.57 | 17,500 | 9,975 | 68,534 | 51 K to 68.5 K (+34.29 %) |
Aug 14 2009 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.45 | 6,885 | 3,098 | 3,414,219 | 3.4 M to 3.4 M (+0.20 %) |
Aug 13 2009 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.45 | 29,567 | 13,305 | 3,407,334 | 3.4 M to 3.4 M (+0.88 %) |
Jul 13 2009 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.49 | 20,000 | 9,800 | 3,377,767 | 3.4 M to 3.4 M (+0.60 %) |
Jun 11 2009 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.49 | 40,000 | 19,600 | 3,357,767 | 3.3 M to 3.4 M (+1.21 %) |
Jun 01 2009 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.50 | 20,000 | 10,000 | 3,317,767 | 3.3 M to 3.3 M (+0.61 %) |
May 29 2009 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.50 | 10,000 | 5,000 | 3,297,767 | 3.3 M to 3.3 M (+0.30 %) |
May 28 2009 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.50 | 10,000 | 5,000 | 3,287,767 | 3.3 M to 3.3 M (+0.31 %) |
May 26 2009 | NUOT | Nuo Therapeutics, ... | Maslan Andrew Scott | Chief Financial Off ... | Buy | P | 0.52 | 2,500 | 1,300 | 47,700 | 45.2 K to 47.7 K (+5.53 %) |
May 26 2009 | NUOT | Nuo Therapeutics, ... | ROSENDALE MARTIN P | Chief Executive Off ... | Buy | P | 0.52 | 2,400 | 1,248 | 51,034 | 48.6 K to 51 K (+4.93 %) |
May 26 2009 | NUOT | Nuo Therapeutics, ... | ROSENDALE MARTIN P | Chief Executive Off ... | Buy | P | 0.51 | 600 | 306 | 48,634 | 48 K to 48.6 K (+1.25 %) |
May 20 2009 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.52 | 10,000 | 5,200 | 3,271,767 | 3.3 M to 3.3 M (+0.31 %) |
May 19 2009 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.52 | 10,000 | 5,200 | 3,261,767 | 3.3 M to 3.3 M (+0.31 %) |
May 15 2009 | NUOT | Nuo Therapeutics, ... | Maslan Andrew Scott | Chief Financial Off ... | Option Exercise | A | 0.60 | 35,000 | 21,000 | 315,000 | |
May 15 2009 | NUOT | Nuo Therapeutics, ... | FYLLING CARELYN P | VP Professional Ser ... | Option Exercise | A | 0.60 | 15,000 | 9,000 | 414,077 | |
Feb 03 2009 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.30 | 18,200 | 5,460 | 3,251,767 | 3.2 M to 3.3 M (+0.56 %) |
Jan 08 2009 | NUOT | Nuo Therapeutics, ... | ROSENDALE MARTIN P | Chief Executive Off ... | Buy | P | 0.39 | 5,000 | 1,950 | 48,334 | 43.3 K to 48.3 K (+11.54 %) |
Jan 06 2009 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Option Exercise | A | 0.35 | 30,000 | 10,500 | 396,667 | |
Jan 06 2009 | NUOT | Nuo Therapeutics, ... | KEITH STEPHEN | Director | Option Exercise | A | 0.35 | 40,000 | 14,000 | 40,000 | |
Jan 06 2009 | NUOT | Nuo Therapeutics, ... | McLoughlin Mark T | Director | Option Exercise | A | 0.35 | 40,000 | 14,000 | 236,667 | |
Jan 06 2009 | NUOT | Nuo Therapeutics, ... | Benson James | Director | Option Exercise | A | 0.35 | 40,000 | 14,000 | 230,000 | |
Jan 06 2009 | NUOT | Nuo Therapeutics, ... | Maslan Andrew Scott | Chief Financial Off ... | Buy | P | 0.27 | 4,300 | 1,161 | 45,200 | 40.9 K to 45.2 K (+10.51 %) |
Jan 06 2009 | NUOT | Nuo Therapeutics, ... | Maslan Andrew Scott | Chief Financial Off ... | Buy | P | 0.25 | 900 | 225 | 40,900 | 40 K to 40.9 K (+2.25 %) |
Jan 05 2009 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.30 | 5,000 | 1,500 | 3,233,567 | 3.2 M to 3.2 M (+0.15 %) |
Dec 30 2008 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.30 | 6,200 | 1,860 | 3,228,567 | 3.2 M to 3.2 M (+0.19 %) |
Dec 30 2008 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.30 | 6,900 | 2,070 | 3,222,367 | 3.2 M to 3.2 M (+0.21 %) |
Dec 29 2008 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.30 | 16,100 | 4,830 | 3,215,467 | 3.2 M to 3.2 M (+0.50 %) |
Dec 29 2008 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.29 | 5,800 | 1,682 | 3,199,367 | 3.2 M to 3.2 M (+0.18 %) |
Dec 17 2008 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 0.40 | 50,000 | 20,000 | 50,000 | |
Dec 17 2008 | NUOT | Nuo Therapeutics, ... | ROSENDALE MARTIN P | Chief Executive Off ... | Option Exercise | A | 0.40 | 200,000 | 80,000 | 716,667 | |
Dec 15 2008 | NUOT | Nuo Therapeutics, ... | Maslan Andrew Scott | Chief Financial Off ... | Buy | P | 0.38 | 4,800 | 1,824 | 40,000 | 35.2 K to 40 K (+13.64 %) |
Dec 15 2008 | NUOT | Nuo Therapeutics, ... | Maslan Andrew Scott | Chief Financial Off ... | Buy | P | 0.34 | 200 | 68 | 35,200 | 35 K to 35.2 K (+0.57 %) |
Dec 15 2008 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.30 | 9,433 | 2,830 | 3,193,567 | 3.2 M to 3.2 M (+0.30 %) |
Dec 12 2008 | NUOT | Nuo Therapeutics, ... | Maslan Andrew Scott | Officer | Buy | P | 0.34 | 6,000 | 2,040 | 35,000 | 29 K to 35 K (+20.69 %) |
Dec 09 2008 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.29 | 10,000 | 2,900 | 3,184,134 | 3.2 M to 3.2 M (+0.32 %) |
Dec 09 2008 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.19 | 10,000 | 1,900 | 3,174,134 | 3.2 M to 3.2 M (+0.32 %) |
Oct 01 2008 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.68 | 10,800 | 7,344 | 3,164,134 | 3.2 M to 3.2 M (+0.34 %) |
Sep 22 2008 | NUOT | Nuo Therapeutics, ... | FYLLING CARELYN P | VP Professional Ser ... | Option Exercise | A | 0.70 | 30,000 | 21,000 | 339,077 | |
Sep 22 2008 | NUOT | Nuo Therapeutics, ... | ROSENDALE MARTIN P | Chief Executive Off ... | Option Exercise | A | 0.75 | 300,000 | 225,000 | 516,667 | |
Sep 22 2008 | NUOT | Nuo Therapeutics, ... | Maslan Andrew Scott | Chief Financial Off ... | Option Exercise | A | 0.70 | 100,000 | 70,000 | 280,000 | |
Sep 09 2008 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Option Exercise | P | 1.00 | 16,667 | 16,667 | 366,667 | |
Sep 09 2008 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Buy | P | 0.75 | 33,334 | 25,001 | 694,957 | 661.6 K to 695 K (+5.04 %) |
Sep 09 2008 | NUOT | Nuo Therapeutics, ... | McLoughlin Mark T | Director | Option Exercise | P | 1.00 | 6,667 | 6,667 | 196,667 | |
Sep 09 2008 | NUOT | Nuo Therapeutics, ... | McLoughlin Mark T | Director | Buy | P | 0.75 | 13,334 | 10,001 | 13,334 | 0 to 13.3 K |
Sep 09 2008 | NUOT | Nuo Therapeutics, ... | Deva Arun K. | Director | Option Exercise | P | 1.00 | 10,000 | 10,000 | 190,000 | |
Sep 09 2008 | NUOT | Nuo Therapeutics, ... | Deva Arun K. | Director | Buy | P | 0.75 | 20,000 | 15,000 | 30,000 | 10 K to 30 K (+200.00 %) |
Sep 09 2008 | NUOT | Nuo Therapeutics, ... | Maslan Andrew Scott | Chief Financial Off ... | Option Exercise | P | 1.00 | 10,000 | 10,000 | 180,000 | |
Sep 09 2008 | NUOT | Nuo Therapeutics, ... | Maslan Andrew Scott | Chief Financial Off ... | Buy | P | 0.75 | 20,000 | 15,000 | 29,000 | 9 K to 29 K (+222.22 %) |
Sep 09 2008 | NUOT | Nuo Therapeutics, ... | ROSENDALE MARTIN P | Chief Executive Off ... | Option Exercise | P | 1.00 | 16,667 | 16,667 | 216,667 | |
Sep 09 2008 | NUOT | Nuo Therapeutics, ... | ROSENDALE MARTIN P | Chief Executive Off ... | Buy | P | 0.75 | 33,334 | 25,001 | 43,334 | 10 K to 43.3 K (+333.34 %) |
Apr 03 2008 | NUOT | Nuo Therapeutics, ... | Maslan Andrew Scott | Chief Financial Off ... | Buy | P | 0.74 | 600 | 444 | 9,000 | 8.4 K to 9 K (+7.14 %) |
Apr 03 2008 | NUOT | Nuo Therapeutics, ... | Maslan Andrew Scott | Chief Financial Off ... | Buy | P | 0.75 | 4,400 | 3,300 | 8,600 | 4.2 K to 8.6 K (+104.76 %) |
Apr 03 2008 | NUOT | Nuo Therapeutics, ... | MOHAN KSHITIJ | Chief Executive Off ... | Buy | P | 0.93 | 2,600 | 2,418 | 20,000 | 17.4 K to 20 K (+14.94 %) |
Apr 03 2008 | NUOT | Nuo Therapeutics, ... | MOHAN KSHITIJ | Chief Executive Off ... | Buy | P | 0.92 | 2,900 | 2,668 | 17,400 | 14.5 K to 17.4 K (+20.00 %) |
Apr 03 2008 | NUOT | Nuo Therapeutics, ... | MOHAN KSHITIJ | Chief Executive Off ... | Buy | P | 0.90 | 4,500 | 4,050 | 14,500 | 10 K to 14.5 K (+45.00 %) |
Apr 03 2008 | NUOT | Nuo Therapeutics, ... | ROSENDALE MARTIN P | Chief Operating Off ... | Buy | P | 0.85 | 800 | 680 | 10,000 | 9.2 K to 10 K (+8.70 %) |
Apr 03 2008 | NUOT | Nuo Therapeutics, ... | ROSENDALE MARTIN P | Chief Operating Off ... | Buy | P | 0.87 | 200 | 174 | 9,200 | 9 K to 9.2 K (+2.22 %) |
Apr 03 2008 | NUOT | Nuo Therapeutics, ... | ROSENDALE MARTIN P | Chief Operating Off ... | Buy | P | 0.79 | 2,600 | 2,054 | 9,000 | 6.4 K to 9 K (+40.63 %) |
Apr 03 2008 | NUOT | Nuo Therapeutics, ... | ROSENDALE MARTIN P | Chief Operating Off ... | Buy | P | 0.88 | 500 | 440 | 6,400 | 5.9 K to 6.4 K (+8.47 %) |
Apr 03 2008 | NUOT | Nuo Therapeutics, ... | ROSENDALE MARTIN P | Chief Operating Off ... | Buy | P | 0.80 | 1,100 | 880 | 5,900 | 4.8 K to 5.9 K (+22.92 %) |
Apr 03 2008 | NUOT | Nuo Therapeutics, ... | ROSENDALE MARTIN P | Chief Operating Off ... | Buy | P | 0.89 | 4,800 | 4,272 | 4,800 | 0 to 4.8 K |
Jan 29 2008 | NUOT | Nuo Therapeutics, ... | MOHAN KSHITIJ | Chief Executive Off ... | Option Exercise | A | 1.50 | 555 | 833 | 1,279,310 | |
Jan 29 2008 | NUOT | Nuo Therapeutics, ... | MOHAN KSHITIJ | Chief Executive Off ... | Option Exercise | A | 1.50 | 13,095 | 19,643 | 1,279,310 | |
Jan 29 2008 | NUOT | Nuo Therapeutics, ... | MOHAN KSHITIJ | Chief Executive Off ... | Option Exercise | A | 1.50 | 10,735 | 16,103 | 1,279,310 | |
Jan 29 2008 | NUOT | Nuo Therapeutics, ... | MOHAN KSHITIJ | Chief Executive Off ... | Option Exercise | A | 1.50 | 34,925 | 52,388 | 1,279,310 | |
Jan 29 2008 | NUOT | Nuo Therapeutics, ... | MOHAN KSHITIJ | Chief Executive Off ... | Option Exercise | A | 1.50 | 30,000 | 45,000 | 1,279,310 | |
Jan 16 2008 | NUOT | Nuo Therapeutics, ... | Benson James | Director | Option Exercise | A | 1.41 | 10,000 | 14,100 | 190,000 | |
Jan 16 2008 | NUOT | Nuo Therapeutics, ... | Benson James | Director | Option Exercise | A | 1.41 | 30,000 | 42,300 | 190,000 | |
Jan 16 2008 | NUOT | Nuo Therapeutics, ... | DROHAN DAVID F | Director | Option Exercise | A | 1.41 | 30,000 | 42,300 | 150,000 | |
Jan 16 2008 | NUOT | Nuo Therapeutics, ... | McLoughlin Mark T | Director | Option Exercise | A | 1.41 | 10,000 | 14,100 | 190,000 | |
Jan 16 2008 | NUOT | Nuo Therapeutics, ... | McLoughlin Mark T | Director | Option Exercise | A | 1.41 | 30,000 | 42,300 | 190,000 | |
Jan 16 2008 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Option Exercise | A | 1.41 | 30,000 | 42,300 | 350,000 | |
Jan 16 2008 | NUOT | Nuo Therapeutics, ... | Deva Arun Kumar | Director | Option Exercise | A | 1.41 | 10,000 | 14,100 | 180,000 | |
Jan 16 2008 | NUOT | Nuo Therapeutics, ... | Deva Arun Kumar | Director | Option Exercise | A | 1.41 | 30,000 | 42,300 | 180,000 | |
Oct 04 2007 | NUOT | Nuo Therapeutics, ... | Deva Arun Kumar | Director | Option Exercise | M | 1.10 | 10,000 | 11,000 | 140,000 | |
Oct 04 2007 | NUOT | Nuo Therapeutics, ... | Deva Arun Kumar | Director | Buy | M | 1.10 | 10,000 | 11,000 | 10,000 | 0 to 10 K |
Oct 01 2007 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Sell | S | 4.44 | 7,000 | 31,080 | 661,623 | 668.6 K to 661.6 K (-1.05 %) |
Oct 01 2007 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Sell | S | 3.84 | 4,500 | 17,280 | 668,623 | 673.1 K to 668.6 K (-0.67 %) |
Oct 01 2007 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Sell | S | 3.92 | 5,000 | 19,600 | 673,123 | 678.1 K to 673.1 K (-0.74 %) |
Oct 01 2007 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Sell | S | 3.75 | 5,000 | 18,750 | 678,123 | 683.1 K to 678.1 K (-0.73 %) |
Oct 01 2007 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Sell | S | 3.77 | 5,500 | 20,735 | 683,123 | 688.6 K to 683.1 K (-0.80 %) |
Oct 01 2007 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Sell | S | 3.75 | 5,000 | 18,750 | 688,623 | 693.6 K to 688.6 K (-0.72 %) |
Oct 01 2007 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Sell | S | 3.72 | 2,500 | 9,300 | 693,623 | 696.1 K to 693.6 K (-0.36 %) |
Oct 01 2007 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Sell | S | 3.76 | 4,000 | 15,040 | 696,123 | 700.1 K to 696.1 K (-0.57 %) |
Oct 01 2007 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Sell | S | 3.71 | 1,500 | 5,565 | 700,123 | 701.6 K to 700.1 K (-0.21 %) |
Jul 31 2007 | NUOT | Nuo Therapeutics, ... | FYLLING CARELYN P | VP Professional Ser ... | Option Exercise | A | 0.88 | 20,000 | 17,600 | 309,077 | |
Jul 31 2007 | NUOT | Nuo Therapeutics, ... | Maslan Andrew Scott | Chief Financial Off ... | Option Exercise | A | 0.88 | 20,000 | 17,600 | 170,000 | |
Jan 05 2007 | NUOT | Nuo Therapeutics, ... | McLoughlin Mark T | Director | Option Exercise | A | 1.10 | 10,000 | 11,000 | 150,000 | |
Jan 05 2007 | NUOT | Nuo Therapeutics, ... | McLoughlin Mark T | Director | Option Exercise | A | 1.10 | 30,000 | 33,000 | 140,000 | |
Jan 05 2007 | NUOT | Nuo Therapeutics, ... | DROHAN DAVID F | Director | Option Exercise | A | 1.10 | 30,000 | 33,000 | 120,000 | |
Jan 05 2007 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Option Exercise | A | 1.10 | 30,000 | 33,000 | 320,000 | |
Jan 05 2007 | NUOT | Nuo Therapeutics, ... | Benson James | Director | Option Exercise | A | 1.10 | 10,000 | 11,000 | 150,000 | |
Jan 05 2007 | NUOT | Nuo Therapeutics, ... | Benson James | Director | Option Exercise | A | 1.10 | 30,000 | 33,000 | 140,000 | |
Jan 05 2007 | NUOT | Nuo Therapeutics, ... | Deva Arun Kumar | Director | Option Exercise | A | 1.10 | 10,000 | 11,000 | 150,000 | |
Jan 05 2007 | NUOT | Nuo Therapeutics, ... | Deva Arun Kumar | Director | Option Exercise | A | 1.10 | 30,000 | 33,000 | 140,000 | |
Nov 17 2006 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Option Exercise | A | 2.23 | 30,000 | 66,900 | 290,000 | |
Nov 17 2006 | NUOT | Nuo Therapeutics, ... | McLoughlin Mark T | Director | Option Exercise | A | 2.23 | 30,000 | 66,900 | 110,000 | |
Nov 17 2006 | NUOT | Nuo Therapeutics, ... | DROHAN DAVID F | Director | Option Exercise | A | 2.23 | 30,000 | 66,900 | 90,000 | |
Nov 17 2006 | NUOT | Nuo Therapeutics, ... | Benson James | Director | Option Exercise | A | 2.23 | 30,000 | 66,900 | 110,000 | |
Nov 17 2006 | NUOT | Nuo Therapeutics, ... | Deva Arun Kumar | Director | Option Exercise | A | 2.23 | 30,000 | 66,900 | 110,000 | |
Nov 07 2006 | NUOT | Nuo Therapeutics, ... | Maslan Andrew Scott | Chief Financial Off ... | Buy | P | 1.14 | 4,000 | 4,560 | 4,000 | 0 to 4 K |
Nov 06 2006 | NUOT | Nuo Therapeutics, ... | DROHAN DAVID F | Director | Buy | P | 1.06 | 2,000 | 2,120 | 2,000 | 0 to 2 K |
Oct 19 2006 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Buy | P | 1.17 | 18,000 | 21,060 | 701,623 | 683.6 K to 701.6 K (+2.63 %) |
Oct 19 2006 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Gift | G | 0.00 | 35,088 | 0 | 701,623 | 736.7 K to 701.6 K (-4.76 %) |
Oct 13 2006 | NUOT | Nuo Therapeutics, ... | Maslan Andrew Scott | Chief Financial Off ... | Option Exercise | A | 2.73 | 50,000 | 136,500 | 150,000 | |
Aug 18 2006 | NUOT | Nuo Therapeutics, ... | MOHAN KSHITIJ | Chief Executive Off ... | Option Exercise | A | 1.50 | 100,000 | 150,000 | 1,190,000 | |
Mar 21 2006 | NUOT | Nuo Therapeutics, ... | Maslan Andrew Scott | CFO | Option Exercise | A | 2.23 | 40,000 | 89,200 | 100,000 | |
Jan 17 2006 | NUOT | Nuo Therapeutics, ... | Deva Arun Kumar | Director | Option Exercise | A | 2.55 | 30,000 | 76,500 | 80,000 | |
Jan 17 2006 | NUOT | Nuo Therapeutics, ... | Deva Arun Kumar | Director | Option Exercise | A | 2.23 | 10,000 | 22,300 | 50,000 | |
Jan 17 2006 | NUOT | Nuo Therapeutics, ... | Benson James | Director | Option Exercise | A | 2.55 | 30,000 | 76,500 | 80,000 | |
Jan 17 2006 | NUOT | Nuo Therapeutics, ... | Benson James | Director | Option Exercise | A | 2.23 | 10,000 | 22,300 | 50,000 | |
Jan 17 2006 | NUOT | Nuo Therapeutics, ... | Maslan Andrew Scott | Chief Financial Off ... | Option Exercise | A | 5.07 | 60,000 | 304,200 | 60,000 | |
Jan 17 2006 | NUOT | Nuo Therapeutics, ... | DROHAN DAVID F | Director | Option Exercise | A | 2.55 | 30,000 | 76,500 | 60,000 | |
Jan 17 2006 | NUOT | Nuo Therapeutics, ... | McLoughlin Mark T | Director | Option Exercise | A | 2.55 | 30,000 | 76,500 | 80,000 | |
Jan 17 2006 | NUOT | Nuo Therapeutics, ... | McLoughlin Mark T | Director | Option Exercise | A | 2.23 | 10,000 | 22,300 | 50,000 | |
Jan 17 2006 | NUOT | Nuo Therapeutics, ... | FYLLING CARELYN P | VP Professional Ser ... | Option Exercise | A | 2.40 | 20,000 | 48,000 | 289,077 | |
Jan 17 2006 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Option Exercise | A | 2.55 | 30,000 | 76,500 | 260,000 | |
Dec 27 2005 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Buy | P | 2.59 | 5,000 | 12,950 | 718,711 | 713.7 K to 718.7 K (+0.70 %) |
Dec 21 2005 | NUOT | Nuo Therapeutics, ... | MOHAN KSHITIJ | Chief Executive Off ... | Option Exercise | M | 1.50 | 10,000 | 15,000 | 1,090,000 | |
Dec 21 2005 | NUOT | Nuo Therapeutics, ... | MOHAN KSHITIJ | Chief Executive Off ... | Buy | M | 1.50 | 10,000 | 15,000 | 10,000 | 0 to 10 K |
Sep 13 2005 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Buy | P | 2.15 | 2,500 | 5,375 | 713,711 | 711.2 K to 713.7 K (+0.35 %) |
Sep 13 2005 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Buy | P | 2.10 | 1,700 | 3,570 | 713,711 | 712 K to 713.7 K (+0.24 %) |
Sep 13 2005 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Buy | P | 2.13 | 5,800 | 12,354 | 713,711 | 707.9 K to 713.7 K (+0.82 %) |
Sep 13 2005 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Buy | P | 5.50 | 25,000 | 137,500 | 713,711 | 688.7 K to 713.7 K (+3.63 %) |
Aug 16 2005 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Option Exercise | X | 1.50 | 7,500 | 11,250 | 0 | |
Aug 16 2005 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Buy | X | 1.50 | 7,500 | 11,250 | 678,711 | 671.2 K to 678.7 K (+1.12 %) |
Jul 05 2005 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Buy | P | 4.50 | 16,455 | 74,048 | 671,211 | 654.8 K to 671.2 K (+2.51 %) |
Jun 23 2005 | NUOT | Nuo Therapeutics, ... | BURKETT ROBERT | Director | Option Exercise | M | 1.15 | 30,000 | 34,500 | 0 | |
Jun 23 2005 | NUOT | Nuo Therapeutics, ... | BURKETT ROBERT | Director | Buy | M | 1.15 | 30,000 | 34,500 | 30,000 | 0 to 30 K |
Jun 08 2005 | NUOT | Nuo Therapeutics, ... | BURKETT ROBERT | Director | Sell | S | 5.07 | 300 | 1,521 | 0 | 300 to 0 (-100.00 %) |
Jun 08 2005 | NUOT | Nuo Therapeutics, ... | BURKETT ROBERT | Director | Sell | S | 5.06 | 1,600 | 8,096 | 0 | 1.6 K to 0 (-100.00 %) |
Jun 08 2005 | NUOT | Nuo Therapeutics, ... | BURKETT ROBERT | Director | Sell | S | 5.05 | 12,700 | 64,135 | 0 | 12.7 K to 0 (-100.00 %) |
Jun 08 2005 | NUOT | Nuo Therapeutics, ... | BURKETT ROBERT | Director | Sell | S | 5.03 | 2,400 | 12,072 | 0 | 2.4 K to 0 (-100.00 %) |
Jun 08 2005 | NUOT | Nuo Therapeutics, ... | BURKETT ROBERT | Director | Sell | S | 5.02 | 1,000 | 5,020 | 0 | 1,000 to 0 (-100.00 %) |
Jun 08 2005 | NUOT | Nuo Therapeutics, ... | BURKETT ROBERT | Director | Sell | S | 5.00 | 13,865 | 69,325 | 0 | 13.9 K to 0 (-100.00 %) |
Jun 08 2005 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Buy | P | 4.50 | 115,116 | 518,022 | 654,756 | 539.6 K to 654.8 K (+21.33 %) |
Jun 07 2005 | NUOT | Nuo Therapeutics, ... | MOHAN KSHITIJ | CEO | Option Exercise | A | 1.50 | 100,000 | 150,000 | 1,100,000 | |
May 27 2005 | NUOT | Nuo Therapeutics, ... | FYLLING CARELYN P | VP Professional Ser ... | Sell | S | 4.00 | 6,500 | 26,000 | 4,298 | 10.8 K to 4.3 K (-60.20 %) |
May 27 2005 | NUOT | Nuo Therapeutics, ... | FYLLING CARELYN P | VP Professional Ser ... | Sell | S | 3.99 | 1,000 | 3,990 | 4,298 | 5.3 K to 4.3 K (-18.88 %) |
May 27 2005 | NUOT | Nuo Therapeutics, ... | FYLLING CARELYN P | VP Professional Ser ... | Sell | S | 3.97 | 1,000 | 3,970 | 4,298 | 5.3 K to 4.3 K (-18.88 %) |
May 27 2005 | NUOT | Nuo Therapeutics, ... | FYLLING CARELYN P | VP Professional Ser ... | Sell | S | 3.95 | 500 | 1,975 | 4,298 | 4.8 K to 4.3 K (-10.42 %) |
May 27 2005 | NUOT | Nuo Therapeutics, ... | FYLLING CARELYN P | VP Professional Ser ... | Sell | S | 3.94 | 500 | 1,970 | 4,298 | 4.8 K to 4.3 K (-10.42 %) |
May 27 2005 | NUOT | Nuo Therapeutics, ... | FYLLING CARELYN P | VP Professional Ser ... | Sell | S | 3.92 | 500 | 1,960 | 4,298 | 4.8 K to 4.3 K (-10.42 %) |
May 27 2005 | NUOT | Nuo Therapeutics, ... | FYLLING CARELYN P | VP Professional Ser ... | Sell | S | 3.90 | 2,500 | 9,750 | 4,298 | 6.8 K to 4.3 K (-36.78 %) |
May 25 2005 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Buy | P | 3.70 | 2,000 | 7,400 | 539,640 | 537.6 K to 539.6 K (+0.37 %) |
May 10 2005 | NUOT | Nuo Therapeutics, ... | CREWS DAVID | Director | Buy | P | 0.00 | 190,116 | 0 | 537,640 | 347.5 K to 537.6 K (+54.71 %) |
Apr 18 2005 | NUOT | Nuo Therapeutics, ... | BURKETT ROBERT | Director | Option Exercise | A | 2.55 | 10,000 | 25,500 | 240,000 | |
Apr 18 2005 | NUOT | Nuo Therapeutics, ... | BURKETT ROBERT | Director | Option Exercise | A | 1.15 | 30,000 | 34,500 | 240,000 | |
Apr 18 2005 | NUOT | Nuo Therapeutics, ... | Benson James | Director | Option Exercise | A | 2.55 | 10,000 | 25,500 | 40,000 |